Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16248525 | 0.87 | NOD1 (0.36) | NOD1 | |
| SCHEMBL16248526 | 0.87 | NOD1 (0.36) | NOD1 | |
| SCHEMBL24119914 | 0.85 | NOD1 (0.35) | NOD1 | |
| SCHEMBL20099412 | 0.82 | NOD1 (0.34) | NOD1 | |
| SCHEMBL17446586 | 0.81 | NOD1 (0.32) | NOD1 | |
| SCHEMBL24119971 | 0.81 | NOD1 (0.35) | NOD1 | |
| SCHEMBL24645940 | 0.80 | NOD1 (0.31) | NOD1 | |
| SCHEMBL20016473 | 0.80 | — | — | |
| SCHEMBL23136493 | 0.79 | NOD1 (0.33) | NOD1 | |
| SCHEMBL20643464 | 0.79 | NOD1 (0.36) | NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210277401-A1 | Compositions and Methods for Modulating PKK Expression | IONIS PHARMACEUTICALS, INC. (US) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210277401-A1 | Compositions and Methods for Modulating PKK Expression | GCKR, PKM, PKLR | NOD1 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.